2025
|
P/S
|
Pharmaceutical research and development |
2024
|
P/S
|
Pharmaceutical research and development. Licensing of pharmaceutical products. |
|
P/S
|
Solubilizing chemical agents for use in the manufacture of
pharmaceutical preparations; solubili... |
|
P/S
|
Solubilizing chemical agents for use in the manufacture of pharmaceutical preparations; Solubiliz... |
2022
|
Invention
|
Cyclic phosphoramidate compounds. Provided herein are cyclic phosphoramidate compounds, their pre... |
|
Invention
|
Nucleotide prodrug compounds. Provided herein are nucleotide prodrug compounds, their preparation... |
|
Invention
|
Unnatural configuration nucleotide prodrug compounds.
Provided herein am phosphoramidate and cyc... |
|
Invention
|
Unnatural configuration nucleotide prodrug compounds. Provided herein are phosphoramidate and cyc... |
|
P/S
|
Pharmaceutical research and development of a process to
deliver pharmaceutical preparations. |
2021
|
Invention
|
Heterocycle amines and uses thereof. Compounds and methods in the fields of chemistry and medicin... |
|
Invention
|
Antiviral prodrug compounds.
Provided herein are nucleotide prodrug compounds, their preparation... |
|
Invention
|
Antiviral prodrug compounds. Provided herein are nucleotide prodrug compounds, their preparation ... |
|
P/S
|
Pharmaceutical research and development of a process to deliver pharmaceutical preparations |
|
P/S
|
Pharmaceutical research and development
Licensing of pharmaceutical products |
|
Invention
|
Benzyloxy phosph(on)ate compounds.
Provided herein are 2-substituted benzyloxy phosph(on)ate com... |
|
Invention
|
Benzyloxy phosph(on)ate compounds. Provided herein are 2-substituted benzyloxy phosph(on)ate comp... |
2020
|
Invention
|
Imidazo-fused heterocycles and uses thereof. Compounds and methods in the fields of chemistry and... |
|
Invention
|
Selective androgen receptor modulators (sarms) and uses thereof. Provided herein are compounds, s... |
|
Invention
|
Methods and compositions associated with the granulocyte colony-stimulating factor receptor. Some... |
|
Invention
|
Cyclic phosphate compounds.
Provided herein are cyclic phosphate compounds, their preparation an... |
|
Invention
|
Cyclic phosphate compounds. Provided herein are cyclic phosphate compounds, their preparation and... |
|
Invention
|
Crystalline forms and methods of producing crystalline forms of a compound.
Disclosed herein are... |
|
Invention
|
Crystalline forms and methods of producing crystalline forms of a compound. Disclosed herein are ... |
2019
|
P/S
|
Pharmaceutical research and development of a process to deliver organ specific pharmaceutical pre... |
|
P/S
|
Pharmaceutical research and development of a process to
deliver organ specific pharmaceutical pr... |
|
Invention
|
Methods and compositions for modulating hormone levels. Provided herein are compositions and meth... |
|
Invention
|
Prodrug compounds and their uses. Provided herein are prodrug compounds, their preparation and th... |
|
Invention
|
Glucagon receptor antagonists. Provided herein are solid state forms of compounds, including enan... |
|
Invention
|
Acetal compounds and therapeutic uses thereof. Disclosed herein are acetal and cyclic acetal comp... |
2018
|
Invention
|
Glucagon antagonists.
Provided herein are compounds, including enantiomerically pure forms there... |
|
Invention
|
Prodrug compounds and uses thereof. Provided herein are cyclic phosphorus-containing prodrug comp... |
|
Invention
|
Method for treating chronic inflammatory diseases.
Methods of administering and pharmaceutical c... |
|
Invention
|
Methods of treatment associated with the granulocyte colony-stimulating factor receptor. Some emb... |
2017
|
Invention
|
Method for treating disorders associated with glomerular function. Methods of administering and p... |
|
Invention
|
Glucagon receptor antagonists.
Provided herein are compounds, including enantiomerically pure fo... |
|
Invention
|
Glucagon receptor antagonists. Provided herein are compounds, including enantiomerically pure for... |
|
Invention
|
Derivatives of uridine 5′-cyclophosphate useful to treat hepatitis c viral infections. Some embod... |
2016
|
P/S
|
Licensing of pharmaceutical products |
|
Invention
|
Gemcitabine derivatives. Compositions and methods in the field of medicine and chemistry are disc... |
2015
|
Invention
|
Prodrug compounds and uses therof. Provided herein are cyclic phosphorus-containing prodrug compo... |
|
Invention
|
Glucagon antagonists. Provided herein are compounds, including enantiomerically pure forms thereo... |
2001
|
P/S
|
Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use... |
1995
|
P/S
|
Medicines for the treatment of cancer conditions.
Medicines for the treatment of cancer and pre-c... |